Mehdi Farshchian

1.5k total citations
49 papers, 924 citations indexed

About

Mehdi Farshchian is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Mehdi Farshchian has authored 49 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Dermatology, 11 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Mehdi Farshchian's work include Autoimmune Bullous Skin Diseases (7 papers), Oral Health Pathology and Treatment (6 papers) and Immunotherapy and Immune Responses (6 papers). Mehdi Farshchian is often cited by papers focused on Autoimmune Bullous Skin Diseases (7 papers), Oral Health Pathology and Treatment (6 papers) and Immunotherapy and Immune Responses (6 papers). Mehdi Farshchian collaborates with scholars based in United States, Finland and Iran. Mehdi Farshchian's co-authors include Veli‐Matti Kähäri, Pilvi Riihilä, Liisa Nissinen, Markku Kallajoki, Juha Peltonen, Atte Kivisaari, Sirkku Peltonen, Reidar Grénman, Abbas Zamanian and Seppo Meri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal Of Pathology.

In The Last Decade

Mehdi Farshchian

46 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehdi Farshchian United States 16 288 274 269 223 174 49 924
Vladimir Ratushny United States 10 247 0.9× 85 0.3× 352 1.3× 186 0.8× 109 0.6× 18 808
Henri Montaudié France 22 209 0.7× 555 2.0× 260 1.0× 425 1.9× 76 0.4× 80 1.4k
Zengbiao Qi United States 16 306 1.1× 692 2.5× 458 1.7× 58 0.3× 151 0.9× 17 1.5k
Asmaa Gaber Abdou Egypt 17 66 0.2× 212 0.8× 244 0.9× 157 0.7× 67 0.4× 101 907
Mark A. Cappel United States 17 422 1.5× 91 0.3× 199 0.7× 349 1.6× 104 0.6× 34 1.2k
A. Möller Germany 12 48 0.2× 475 1.7× 197 0.7× 135 0.6× 57 0.3× 19 973
Sophie Allart France 18 261 0.9× 272 1.0× 312 1.2× 21 0.1× 51 0.3× 31 1.0k
Sarah Guégan France 16 122 0.4× 206 0.8× 336 1.2× 126 0.6× 26 0.1× 43 1.0k
Jinsong Hu China 19 152 0.5× 278 1.0× 747 2.8× 24 0.1× 344 2.0× 50 1.5k
Riccardo G. Borroni Italy 15 226 0.8× 183 0.7× 114 0.4× 217 1.0× 19 0.1× 58 659

Countries citing papers authored by Mehdi Farshchian

Since Specialization
Citations

This map shows the geographic impact of Mehdi Farshchian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Farshchian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Farshchian more than expected).

Fields of papers citing papers by Mehdi Farshchian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehdi Farshchian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Farshchian. The network helps show where Mehdi Farshchian may publish in the future.

Co-authorship network of co-authors of Mehdi Farshchian

This figure shows the co-authorship network connecting the top 25 collaborators of Mehdi Farshchian. A scholar is included among the top collaborators of Mehdi Farshchian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehdi Farshchian. Mehdi Farshchian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasiri, Mohammad Javad, et al.. (2025). Treatment of Solar Lentigines: A Systematic Review of Clinical Trials. Journal of Cosmetic Dermatology. 24(4). e70133–e70133.
2.
Potts, Geoffrey, et al.. (2022). Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics. Dermatology and Therapy. 12(12). 2705–2714. 6 indexed citations
3.
Ruterbusch, Julie J., et al.. (2021). Racial Disparities in Patients with Melanoma: A Multivariate Survival Analysis. Clinical Cosmetic and Investigational Dermatology. Volume 14. 547–550. 19 indexed citations
4.
Farshchian, Mehdi, et al.. (2021). The status of treatment for plantar warts in 2021: No definitive advancements in decades for a common dermatology disease. Clinics in Dermatology. 39(4). 688–694. 21 indexed citations
5.
Farshchian, Mehdi, et al.. (2021). Oral nail growth supplements: a comprehensive review. International Journal of Dermatology. 61(8). 916–922. 2 indexed citations
6.
Farshchian, Mehdi, Arash Kimyai‐Asadi, & Steven Daveluy. (2021). Cryosnip for skin tag removal. Journal of the American Academy of Dermatology. 89(3). e113–e114. 1 indexed citations
7.
Piipponen, Minna, Liisa Nissinen, Pilvi Riihilä, et al.. (2019). p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling. American Journal Of Pathology. 190(2). 503–517. 36 indexed citations
8.
Riihilä, Pilvi, Liisa Nissinen, Mehdi Farshchian, et al.. (2017). 540 Tumor cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma. Journal of Investigative Dermatology. 137(10). S285–S285. 2 indexed citations
9.
Nissinen, Liisa, Mehdi Farshchian, Pilvi Riihilä, & Veli‐Matti Kähäri. (2016). New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma. Cell and Tissue Research. 365(3). 691–702. 61 indexed citations
10.
Kimyai‐Asadi, Arash, et al.. (2015). Drug-induced skin reactions: a 2-year study. Clinical Cosmetic and Investigational Dermatology. 8. 53–53. 13 indexed citations
11.
Farshchian, Mehdi, Liisa Nissinen, Elina Siljamäki, et al.. (2015). EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 135(7). 1882–1892. 45 indexed citations
12.
Riihilä, Pilvi, Liisa Nissinen, Mehdi Farshchian, et al.. (2014). Complement Factor I Promotes Progression of Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 135(2). 579–588. 65 indexed citations
13.
Farshchian, Mehdi, Johanna Tuomela, Jouko Sandholm, et al.. (2014). Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone. PLoS ONE. 9(8). e105526–e105526. 9 indexed citations
14.
Farshchian, Mehdi, et al.. (2012). IMMUNOFLUORESCENCE PATTERN OF AUTOIMMUNE BULLOUS DISEASES IN IRANIAN PATIENTS. Iranian journal of pathology. 7(4). 231–235. 2 indexed citations
15.
Moravvej, Hamideh, et al.. (2008). Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: A retrospective study. Indian Journal of Dermatology Venereology and Leprology. 74(6). 607–607. 12 indexed citations
16.
Kashani, Mansour Nassiri, et al.. (2007). FREQUENCY OF CONTACT SENSITIZATION TO EUROPEAN STANDARD SERIES (ESS) IN CONTACT AND/OR ATOPIC DERMATITIS PATIENTS IN RASHT, AHWAZ, KERMAN AND HAMEDAN. 10(341). 187–195. 1 indexed citations
17.
Zamanian, Abbas & Mehdi Farshchian. (2007). Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.. PubMed. 6(7). 703–6. 3 indexed citations
18.
Farshchian, Mehdi, et al.. (2007). Serum lipid level in Iranian patients with psoriasis. Journal of the European Academy of Dermatology and Venereology. 21(6). 802–805. 58 indexed citations
19.
Farshchian, Mehdi, et al.. (2001). Evaluation of Characteristics of Pemphigus Patients Hospitalized in the Dermatology Ward of Sina Hospital Hamadan – Iran During 1992-1995. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Farshchian, Mehdi, et al.. (2000). PHAKOMATOSIS PIGMENTOVASCULARIS : A CASE REPORT. 3(311). 42–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vladimir Ratushny Breakdown of academic impact, for papers by Henri Montaudié Breakdown of academic impact, for papers by Zengbiao Qi Breakdown of academic impact, for papers by Asmaa Gaber Abdou Breakdown of academic impact, for papers by Mark A. Cappel Breakdown of academic impact, for papers by A. Möller Breakdown of academic impact, for papers by Sophie Allart Breakdown of academic impact, for papers by Sarah Guégan Breakdown of academic impact, for papers by Jinsong Hu Breakdown of academic impact, for papers by Riccardo G. Borroni
Rankless by CCL
2026